Intestinal Fistula Treatment Market is set to Grow at a Remarkable Pace by 2033
In 2023, the global intestinal fistula treatment market is anticipated to be worth US$ 26.64 billion. With ongoing advancements in pharmaceuticals and biotechnology, the global demand for intestinal fistula therapy is expected to expand at a CAGR of 5.8% between 2023 and 2033, reaching approximately US$ 46.82 billion by 2033. Factors such as an increasing prevalence of ulcerative colitis and Crohn’s disease, and the increasing awareness of the disease globally are expected to propel the growth of the intestinal fistula treatment market over the forecast period. Hence, various key industry players are focusing on R&D and exploring new potential candidates for the treatment of intestinal fistula. As per ClinicalTrials.gov., more than 145 clinical studies are active for ulcerative colitis and Crohn’s disease. The majority of the molecules are in phases 3 & 4 of the clinical trials. For instance, Eli Lilly and Company used mirikizumab drug in phase 3 of clinical trials to ev...